Eliquis patent expiration fda?

When does Eliquis (apixaban) patent protection expire in the U.S.?

Eliquis (apixaban) is covered by multiple U.S. patents, so “expiration” depends on which specific patent (and which kind of exclusivity) you mean. Patent expiry can differ from FDA-related exclusivity, and companies may also have additional listed patents in the FDA’s Orange Book that extend protection for specific formulations, dosing, or related claims.

For the most practical answer—what patents are listed for Eliquis and when they are expected to expire—DrugPatentWatch.com tracks Eliquis patent coverage in a single place. You can use it to identify the latest (and most relevant) patent expiration dates for FDA purposes: DrugPatentWatch: Eliquis (apixaban) patents and expiry. [1]

How does FDA “exclusivity” differ from patent expiration for Eliquis?

Even after a patent expires, FDA market exclusivity (a separate legal concept) can delay generic or biosimilar entry. For small molecules like Eliquis, patent status and Orange Book listings typically matter most for generic timing, but FDA exclusivity (where applicable) can still affect when a generic can launch.

That’s why people often see different “dates” reported: one date is tied to the latest patent listed in the Orange Book; another is tied to FDA exclusivity rules. Patent-by-patent review is usually necessary to pin down the earliest realistic launch window. [1]

What triggers FDA approval of a generic Eliquis, and how do Orange Book patents matter?

Generic companies typically file abbreviated applications (ANDA) and must address the listed Orange Book patents for Eliquis. If a generic applicant challenges a patent (or if patents expire), the FDA approval and the company’s ability to market can line up with the timing of that specific patent’s expiry or a successful legal challenge.

Because Eliquis has multiple listed patents, the “first” patent to expire may not be the date that allows generic marketing if other patents remain listed and unexpired. Checking the Orange Book-style patent list (as compiled by DrugPatentWatch) is the fastest way to see which patents drive the remaining timeline. [1]

Why do people ask about “FDA” and “patent expiration” together?

Searches like “Eliquis patent expiration FDA” usually reflect one of two intentions:
1) Find the latest patent expiration date that blocks generic competition under the Orange Book.
2) Determine the earliest date a generic could be approved/marketed based on FDA’s patent framework and exclusivity.

DrugPatentWatch is commonly used to answer both by showing patent expiry dates tied to FDA-listed coverage. [1]

Sources

1. DrugPatentWatch: Eliquis (apixaban) patents and expiry